Cytokeratin 19 fragments (CK19) are expressed in almost all epithelial malignancies, including breast cancer, lung cancer, colorectal carcinoma, cervical carcinoma, and papillary thyroid carcinoma. This evidence concerns the gene KRT19 and lung carcinoma.